Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis.

Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

PLoS One. 2019 Aug 5;14(8):e0220531. doi: 10.1371/journal.pone.0220531. eCollection 2019.

2.

Long-term spinal mobility in ankylosing spondylitis: a repeated cross-sectional study.

Sundström B, Ljung L, Hörnberg K, Wållberg-Jonsson S.

Arthritis Care Res (Hoboken). 2019 May 17. doi: 10.1002/acr.23929. [Epub ahead of print]

PMID:
31099987
3.

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator.

Wahlin B, Innala L, Magnusson S, Möller B, Smedby T, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

J Rheumatol. 2019 Feb;46(2):130-137. doi: 10.3899/jrheum.171008. Epub 2018 Oct 1.

PMID:
30275258
4.

Exercise habits and C-reactive protein may predict development of spinal immobility in patients with ankylosing spondylitis.

Sundström B, Ljung L, Wållberg-Jonsson S.

Clin Rheumatol. 2018 Oct;37(10):2881-2885. doi: 10.1007/s10067-018-4195-y. Epub 2018 Jul 18.

5.

Mosquitoborne Sindbis Virus Infection and Long-Term Illness.

Gylfe Å, Ribers Å, Forsman O, Bucht G, Alenius GM, Wållberg-Jonsson S, Ahlm C, Evander M.

Emerg Infect Dis. 2018 Jun;24(6):1141-1142. doi: 10.3201/eid2406.170892.

6.

Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease.

Hörnberg K, Sundström B, Innala L, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

PLoS One. 2017 Dec 22;12(12):e0190211. doi: 10.1371/journal.pone.0190211. eCollection 2017.

7.

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel PLCM, Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, Laar MV, Vonkeman HE, Meek I, Semb AG; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).

Ann Rheum Dis. 2018 Jan;77(1):48-54. doi: 10.1136/annrheumdis-2017-211735. Epub 2017 Sep 6.

8.

Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.

Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J.

Ann Rheum Dis. 2017 Dec;76(12):2017-2024. doi: 10.1136/annrheumdis-2017-211608. Epub 2017 Aug 20.

PMID:
28823986
9.

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT.

Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3. Review.

PMID:
27697765
10.

Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study.

Wahlin B, Meedt T, Jonsson F, Henein MY, Wållberg-Jonsson S.

Biomed Res Int. 2016;2016:1261582. doi: 10.1155/2016/1261582. Epub 2016 Aug 28.

11.

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.

Gunnarsson N, Höglund M, Stenke L, Wållberg-Jonsson S, Sandin F, Björkholm M, Dreimane A, Lambe M, Markevärn B, Olsson-Strömberg U, Wadenvik H, Richter J, Själander A.

Leukemia. 2016 Jul;30(7):1562-7. doi: 10.1038/leu.2016.59. Epub 2016 Mar 8.

PMID:
27080811
12.

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters.

Innala L, Sjöberg C, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2016 Jan 28;18:33. doi: 10.1186/s13075-016-0928-y.

13.

Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Biomed Res Int. 2015;2015:673018. doi: 10.1155/2015/673018. Epub 2015 Oct 4.

14.

Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome.

Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J.

Eur Heart J. 2015 Dec 21;36(48):3413-22. doi: 10.1093/eurheartj/ehv461. Epub 2015 Sep 23.

PMID:
26400826
15.

The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.

Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

J Rheumatol. 2015 Jun;42(6):935-42. doi: 10.3899/jrheum.140694. Epub 2015 Apr 15.

PMID:
25877503
16.

Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis.

Ruge T, Södergren A, Wållberg-Jonsson S, Larsson A, Arnlöv J.

Scand J Rheumatol. 2014;43(5):371-3. doi: 10.3109/03009742.2014.882979. Epub 2014 May 14.

PMID:
24825074
17.

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.

Innala L, Berglin E, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2014 Apr 14;16(2):R94. doi: 10.1186/ar4540.

18.

The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.

Öhman M, Öhman ML, Wållberg-Jonsson S.

Scand J Rheumatol. 2014;43(4):259-64. doi: 10.3109/03009742.2013.877158. Epub 2014 Apr 2.

PMID:
24689997
19.

Modifiable cardiovascular risk factors in patients with ankylosing spondylitis.

Sundström B, Johansson G, Johansson I, Wållberg-Jonsson S.

Clin Rheumatol. 2014 Jan;33(1):111-7. doi: 10.1007/s10067-013-2410-4. Epub 2013 Oct 19.

PMID:
24135890
20.

Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.

Holmqvist ME, Neovius M, Eriksson J, Mantel Ä, Wållberg-Jonsson S, Jacobsson LT, Askling J.

JAMA. 2012 Oct 3;308(13):1350-6. doi: 10.1001/2012.jama.11741.

PMID:
23032551
21.

Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis.

Holmqvist M, Gränsmark E, Mantel A, Alfredsson L, Jacobsson LT, Wallberg-Jonsson S, Askling J.

Ann Rheum Dis. 2013 Apr;72(4):541-6. doi: 10.1136/annrheumdis-2012-201387. Epub 2012 May 18.

PMID:
22610975
22.

Plasma phospholipid fatty acid content is related to disease activity in ankylosing spondylitis.

Sundström B, Johansson G, Kokkonen H, Cederholm T, Wållberg-Jonsson S.

J Rheumatol. 2012 Feb;39(2):327-33. doi: 10.3899/jrheum.110575. Epub 2011 Dec 15.

PMID:
22174215
23.

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.

Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, Öhman ML, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2011 Aug 15;13(4):R131. doi: 10.1186/ar3442.

24.

A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.

Salomonsson S, Dzikaite V, Zeffer E, Eliasson H, Ambrosi A, Bergman G, Fernlund E, Theander E, Ohman A, Rydberg A, Skogh T, Wållberg-Jonsson S, Elfving A, Fored M, Ekbom A, Lundström U, Mellander M, Winqvist O, Sonesson SE, Gadler F, Jonzon A, Wahren-Herlenius M.

Scand J Immunol. 2011 Nov;74(5):511-7. doi: 10.1111/j.1365-3083.2011.02610.x.

25.

Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis.

Sundström B, Wållberg-Jonsson S, Johansson G.

Clin Rheumatol. 2011 Jan;30(1):71-6. doi: 10.1007/s10067-010-1625-x. Epub 2010 Nov 27.

PMID:
21110212
26.

Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness.

Södergren A, Karp K, Boman K, Eriksson C, Lundström E, Smedby T, Söderlund L, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2010;12(4):R158. doi: 10.1186/ar3116. Epub 2010 Aug 16.

27.

Health-related quality of life in Swedish men and women with early rheumatoid arthritis.

West E, Wållberg-Jonsson S.

Gend Med. 2009 Dec;6(4):544-54. doi: 10.1016/j.genm.2009.12.001.

PMID:
20114005
28.

Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study.

Berglund S, Södergren A, Wållberg Jonsson S, Rantapää Dahlqvist S.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):822-5.

PMID:
19917166
29.

Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis.

Södergren A, Stegmayr B, Ohman ML, Wållberg-Jonsson S.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4):641-4.

PMID:
19772797
30.

Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.

Wållberg-Jonsson S, Caidahl K, Klintland N, Nyberg G, Rantapää-Dahlqvist S.

Scand J Rheumatol. 2008 Jan-Feb;37(1):1-5. doi: 10.1080/03009740701633238.

PMID:
18189187
31.

Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis.

Arlestig L, Wållberg Jonsson S, Stegmayr B, Rantapää-Dahlqvist S.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):866-71.

PMID:
18173921
32.

Interleukin-1 receptor antagonist is associated with both lipid metabolism and inflammation in rheumatoid arthritis.

Ljung L, Olsson T, Engstrand S, Wållberg-Jonsson S, Söderberg S, Rantapää-Dahlqvist S.

Clin Exp Rheumatol. 2007 Jul-Aug;25(4):617-20.

PMID:
17888220
33.

Life satisfaction in early rheumatoid arthritis: a prospective study.

Karlsson B, Berglin E, Wållberg-Jonsson S.

Scand J Occup Ther. 2006 Sep;13(3):193-9.

PMID:
17042467
34.

Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis.

Södergren A, Stegmayr B, Lundberg V, Ohman ML, Wållberg-Jonsson S.

Ann Rheum Dis. 2007 Feb;66(2):263-6. Epub 2006 Jul 19.

35.

Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?

Wållberg-Jonsson S, Ohman M, Rantapää-Dahlqvist S.

Scand J Rheumatol. 2004;33(6):373-9.

PMID:
15794194
36.

Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment.

Yxfeldt A, Wållberg-Jonsson S, Hultdin J, Rantapää-Dahlqvist S.

Scand J Rheumatol. 2003;32(4):205-10.

PMID:
14626626
37.

Is there an increased prevalence of C. pneumoniae and H. pylori in patients with rheumatoid arthritis?

Yxfeldt A, Boman J, Wållberg-Jonsson S.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5):676-7. No abstract available.

PMID:
14611127
38.

Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.

Cvetkovic JT, Wållberg-Jonsson S, Ahmed E, Rantapää-Dahlqvist S, Lefvert AK.

Rheumatology (Oxford). 2002 Sep;41(9):988-95.

PMID:
12209031
39.

Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.

Wållberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapää-Dahlqvist S.

J Rheumatol. 2002 May;29(5):875-82.

PMID:
12022343
40.

Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.

Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B, Rantapaa-Dahlqvist S, Lefvert AK.

J Rheumatol. 2002 Feb;29(2):212-9.

PMID:
11838837
41.

Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis.

Alenius GM, Jonsson S, Wållberg Jonsson S, Ny A, Rantapää Dahlqvist S.

Clin Exp Rheumatol. 2001 Nov-Dec;19(6):760. No abstract available.

PMID:
11791658
42.

Increased content of bombesin/GRP in human synovial fluid in early arthritis: different pattern compared with substance P.

Westermark T, Rantapää-Dahlqvist S, Wållberg-Jonsson S, Kjörell U, Forsgren S.

Clin Exp Rheumatol. 2001 Nov-Dec;19(6):715-20.

PMID:
11791645
43.

Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study.

Wållberg-Jonsson S, Cederfelt M, Rantapää Dahlqvist S.

J Rheumatol. 2000 Jan;27(1):71-5.

PMID:
10648020
44.

Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.

Wållberg-Jonsson S, Johansson H, Ohman ML, Rantapää-Dahlqvist S.

J Rheumatol. 1999 Dec;26(12):2562-71.

PMID:
10606363
45.

Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.

Wallberg-Jonsson S, Ohman ML, Dahlqvist SR.

J Rheumatol. 1997 Mar;24(3):445-51.

PMID:
9058647
46.

Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis.

Wållberg-Jonsson S, Dahlén G, Johnson O, Olivecrona G, Rantapää-Dahlqvist S.

J Intern Med. 1996 Dec;240(6):373-80.

PMID:
9010384
47.
48.

Lipoprotein(a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica.

Wållberg-Jonsson S, Uddhammar A, Dahlén G, Rantapää-Dahlqvist S.

Scand J Clin Lab Invest. 1995 Jul;55(4):309-15.

PMID:
7569733
49.

Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.

Wållberg-Jonsson S, Dahlén GH, Nilsson TK, Rånby M, Rantapää-Dahlqvist S.

Clin Rheumatol. 1993 Sep;12(3):318-24.

PMID:
8258230
50.

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Rantapää-Dahlqvist S, Wållberg-Jonsson S, Dahlén G.

Ann Rheum Dis. 1991 Jun;50(6):366-8.

Supplemental Content

Loading ...
Support Center